Russia Starts Testing Sputnik V COVID-19 Vaccine on Volunteers Aged Over 60

Russia Starts Testing Sputnik V COVID-19 Vaccine on Volunteers Aged Over 60

“We have launched trials of the Sputnik V vaccine, developed by the Russian Health Ministry’s Gamaleya Research Institute of Epidemiology and Microbiology, on volunteers who are older than 60”, Murashko said.

It is crucially important to develop special vaccination parameters for the elderly patients, the health minister stressed.

 


©
Sputnik / Georgy Zimarev
Sputnik V Vaccine

In August, Sputnik V, developed by the Gamaleya research institute, became the world’s first registered vaccine against COVID-19.

 

Russia is expected to boost its production to 1.5 million doses in December, 3-3.5 million doses in January, and up to 15 million doses monthly in the spring, according to Trade Minister Denis Manturov.


©
Sputnik / AFK Sistema press service

Sputnik News

South Africa Today – World News – Russia

Disclaimer: The views of authors published on South Africa Today are their own and do not necessarily represent the views of South Africa Today. By viewing, visiting, using, or interacting with SouthAfricaToday.net, you are agreeing to all the provisions of the Terms of Use Policy and the Privacy Policy.